Wim Van Hecke

, PhD

Founder and CEO, icometrix

Wim Van Hecke, PhD, is the founder and CEO of icometrix, a leading technology company that is focused on improving the lives of people with neurological conditions. The FDA-cleared and CE-marked icobrain AI solution quantifies clinically meaningful information from brain MRI and CT scans. Specifically for Alzheimer's disease and dementia, icobrain evaluates volumes of the hippocampus, different brain lobes, and so on in individuals and compares these with a large healthy population. A specific solution for ARIA monitoring has been developed in collaboration with the pharmaceutical industry and is FDA-pending. Dr. Van Hecke is an academic engineer by training with two master's degrees in applied biomedical engineering and neuroimaging, and a PhD in medicine. He is the author of more than 250 scientific publications and the editor of a clinical neuroimaging handbook. He is also a visiting professor at the University of Brussels.

Read more

This Speaker's Sessions

Wednesday Oct. 18
2:30-3:15 PM
Watch Replay
Now Live!

One Size Fits One: Precision Medicine and Alzheimer’s Prevention

Proactive, precision, whole health medicine is the next frontier in healthcare. What does this mean for Alzheimer’s? Learn how advances in technology, lifestyle medicine, and preventive therapeutics help not only prevent chronic conditions like heart disease and diabetes but also maintain cognition into older years. It is never too early to talk about brain health. Key Question: How are the latest approaches and cutting-edge modalities giving health professionals an edge against Alzheimer’s?

View SessionWatch Replay